Abnormal metabolic control in the septic multiple organ failure syndrome: pharmacotherapy for altered fuel control mechanisms.
Siegel
J H
JH
MIEMSS: University of Maryland, Department of Surgery, Baltimore 21201.
Vary
T C
TC
Rivkind
A
A
Bilik
R
R
Coleman
B
B
Tall
B E
BE
Morris
J G
JG
D000818:Animals; D002245:Carbon Dioxide / Q000378:metabolism; D004734:Energy Metabolism; D005947:Glucose / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D008055:Lipids / Q000627:therapeutic use; D009102:Multiple Organ Failure / Q000503:physiopathology*; D010289:Parenteral Nutrition, Total; D011768:Pyruvate Dehydrogenase Complex / Q000378:metabolism; D012128:Respiratory Distress Syndrome / Q000378:metabolism; D018805:Sepsis / Q000150:complications / Q000378:metabolism*
D008055:Lipids; D011768:Pyruvate Dehydrogenase Complex; D002245:Carbon Dioxide; D005947:Glucose